Current bounty
$500
confidence
0.50
Description
Test whether chromatin accessibility changes are upstream drivers of neurodegeneration rather than downstream effects. If true, targeting chromatin regulators should alter disease course.
Scores
Market Price
0.500
Funding curve
No funders yet — be the first to back this challenge.
Cumulative-token contributions to the bounty will plot here as a curve.